Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs?

Autor: Aikawa NE; Division of Rheumatology, CEDMAC Unit, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil. nadia.aikawa@gmail.com, Twardowsky Ade O, Carvalho JF, Silva CA, Silva IL, Ribeiro AC, Saad CG, Moraes JC, Toledo RA, Bonfá E

Publikováno v: Clinics (Sao Paulo, Brazil) [Clinics (Sao Paulo)] 2011; Vol. 66 (7), pp. 1171-5.